Kobayashi Pharmaceutical Co Ltd
TSE:4967
Kobayashi Pharmaceutical Co Ltd
EPS (Diluted)
Kobayashi Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
EPS (Diluted)
¥238
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Shiseido Co Ltd
TSE:4911
|
EPS (Diluted)
¥46
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-3%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
EPS (Diluted)
¥135
|
CAGR 3-Years
23%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
EPS (Diluted)
¥43
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
EPS (Diluted)
¥119
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-3%
|
|
F
|
Fancl Corp
TSE:4921
|
EPS (Diluted)
¥72
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
21%
|
See Also
What is Kobayashi Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
238.2
JPY
Based on the financial report for Mar 31, 2024, Kobayashi Pharmaceutical Co Ltd's EPS (Diluted) amounts to 238.2 JPY.
What is Kobayashi Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%
Over the last year, the EPS (Diluted) growth was -10%. The average annual EPS (Diluted) growth rates for Kobayashi Pharmaceutical Co Ltd have been -1% over the past three years , 1% over the past five years , and 5% over the past ten years .